We propose that these brakes on UCP1 activity represent potential targets of therapeutic interventions to unlock constraints and efficiently and fully harness the energy-converting potential of brown fat to prevent and treat obesity and associated metabolic disorders. The gene discussed is UCP1; the disease is obesity disorder.